PREVALENCE OF SARCOPENIA ASSESSED BY DEXA IN ELDERLY PATIENTS WITH CHRONIC HEART FAILURE
Main Article Content
Abstract
Background: Sarcopenia is common in elderly patients with chronic heart failure, driven by overlapping pathophysiological mechanisms and age-related musculoskeletal decline. It contributes to reduced physical function and increased risks of adverse outcomes. Accurate assessment using dual-energy X-ray absorptiometry (DEXA) is essential for optimizing comprehensive care in this population.Objective: To investigate the prevalence and associated factors of sarcopenia in elderly outpatients with chronic heart failure. Methods: A cross-sectional study was conducted among elderly outpatients with chronic heart failure at Military Hospital 175 from October 2024 to July 2025. Sarcopenia was diagnosed using dual-energy X-ray absorptiometry (DEXA) based on the Asian Working Group for Sarcopenia (AWGS) 2019 criteria. Logistic regression was used to identify associated factors. Results: Among 244 patients (mean age 68.9 ± 6.7 years; 62.7% male), sarcopenia was present in 126 cases (52.8%). Significant factors associated with sarcopenia included age ≥ 70 years (OR = 2.03; 95% CI: 1.08–3.81; p = 0.027), underweight or normal body weight (OR = 4.18; 95% CI: 2.24–7.82; p < 0.001), depression (OR = 3.52; 95% CI: 1.58–7.82; p = 0.002), and use of aldosterone antagonists (OR = 2.05; 95% CI: 1.14–3.66; p = 0.016). Conclusion: In elderly outpatients with chronic heart failure, the prevalence of sarcopenia was 52.8%. Older age, lower body mass index, depression, and aldosterone antagonist use are independently associated with increased risk of sarcopenia.
Article Details
Keywords
elderly patients, DEXA, sarcopenia, chronic heart failure, outpatient
References
2. Chen R, Xu J, Wang Y, et al. Prevalence of sarcopenia and its association with clinical outcomes in heart failure: An updated meta-analysis and systematic review. Clin Cardiol. Mar 2023;46(3):260-268. doi:10.1002/clc.23970
3. Mirzai S, Eck BL, Chen P-H, Estep JD, Tang WHW. Current Approach to the Diagnosis of Sarcopenia in Heart Failure: A Narrative Review on the Role of Clinical and Imaging Assessments. Circulation: Heart Failure. 2022;15(10):e009322. doi:doi:10.1161/CIRCHEARTFAILURE.121.009322
4. Tân NV, Viên BÁ, Hậu NTM. Nghiên cứu ảnh hưởng của thiếu cơ trên tiên lượng ngắn hạn ở bệnh nhân cao tuổi suy tim mạn tính. Journal of 108 - Clinical Medicine and Phamarcy. 2024;doi:10.52389/ydls.v19i3.2199
5. Nozaki Y, Yamaji M, Nischiguchi S, Fukutani N, Tashiro Y, Shirooka H. Sarcopenia predicts adverse outcomes in an elderly outpatient population with New York heart association class II–IV heart failure: a prospective cohort study. Aging Med Healthcare. 2019; 10 (2): 53–61. 2019.
6. Kamiya K, Hamazaki N, Matsuzawa R, et al. Sarcopenia: Prevalence and Prognostic Implications in Elderly Patients with Cardiovascular Disease. JCSM Clinical Reports. 2017; 2(2): 1-13. doi:https://doi.org/10.17987/ jcsm-cr.v2i2.41
7. Nguyen TN, Nguyen TN, Nguyen AT, et al. Prevalence of sarcopenia and its associated factors in patients attending geriatric clinics in Vietnam: a cross-sectional study. BMJ Open. Sep 17 2020; 10(9): e037630. doi:10.1136/bmjopen-2020-037630
8. Nguyễn BH, Nguyễn TTH, Nguyễn NT, Trần VL, Nguyễn TA. Sarcopenia ở người bệnh cao tuổi có suy tim mạn tính. Tạp chí Y học Việt Nam. 02/19 2023;522(2)doi:10.51298/vmj.v522i2.4318
9. Meng X, Wang Z, Lyu L. Bidirectional association between sarcopenia and depression: A systematic review and meta-analysis. Arch Gerontol Geriatr. May 2025;132:105787. doi:10.1016/j.archger.2025.105787
10. Numazawa R, Katano S, Yano T, et al. Independent Link Between Use of Mineralocorticoid Receptor Antagonists and Muscle Wasting in Heart Failure Patients Not Receiving Renin-Angiotensin System Inhibitors. Circ J. Dec 25 2023;88(1):10-19. doi:10.1253/ circj.CJ-23-0567